Tender Details

Country: USA
Summary: Atropine Auto-Injectors (0.5 mg, 1 mg, and 2 mg)
UST Ref No: 124774801
Deadline: 03 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: AA-I08192025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
This is a NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT under the authority of FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The Office of the Administration for Strategic Preparedness and Response (ASPR), Center for the Strategic National Stockpile (SNS) intends to award a sole source firm fixed price contract to:
Manufacturer Name
Rafa Laboratories LTD
Jerusalem, Israel 97770
The purpose of this acquisition is to provide the United States Government (USG) with pharmaceutical required to support the SNS/CHEMPACK mission. Atropine auto-injectors (0.5 mg, 1 mg, and 2 mg) are essential for future readiness and response to nerve agent or organophosphate poisoning. For emergencies like chemical attacks or accidental exposures, immediate treatment is vital, emphasizing the need for readily available auto-injectors to enable swift response by emergency personnel.
The USG has a need to procure Atropine auto-injectors (0.5 mg, 1 mg, and 2 mg), a U.S. Food and Drug Administration (FDA)-approved and FDA-approved Emergency Use Authorization (EUA) and commercial pharmaceutical, to be utilized during national emergencies and staged in CHEMPACK forward deployed operations at the local level. The USG intends to procure the following: Base Year Ordering Period (1): 2025 - 394,050 EA auto injectors (187,250 ea. of 0.5 mg, 172,800 ea. of 1 mg, and 34,000 ea. of 2 mg)
Optional Ordering Period Year (2): 2026 - 212,000 EA auto injectors (72,000 ea. of 0.5 mg, 72,000 ea. of 1 mg, and 68,000 ea. of 2 mg)
Optional Ordering Period Year (3): 2027 - 212,000 EA auto injectors (72,000 ea. of 0.5 mg, 72,000 ea. of 1 mg, and 68,000 ea. of 2 mg)
Rafa Laboratories is currently the sole manufacturer of Atropine auto-injectors (0.5 mg, 1 mg, and 2 mg). They have no relationships with resellers or distributors for this product.
This notice is for informational and planning purposes...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Atropine Auto-Injectors (0.5 mg, 1 mg, and 2 mg) - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE, a Government sector organization in USA, has announced a new tender for Atropine Auto-Injectors (0.5 mg, 1 mg, and 2 mg). This tender is published on USARFP under UST Ref No: 124774801 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-03.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.